GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NeuPath Health Inc (TSXV:NPTH) » Definitions » Operating Income

NeuPath Health (TSXV:NPTH) Operating Income : C$1.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is NeuPath Health Operating Income?

NeuPath Health's Operating Income for the three months ended in Jun. 2024 was C$0.74 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 was C$1.00 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. NeuPath Health's Operating Income for the three months ended in Jun. 2024 was C$0.74 Mil. NeuPath Health's Revenue for the three months ended in Jun. 2024 was C$18.88 Mil. Therefore, NeuPath Health's Operating Margin % for the quarter that ended in Jun. 2024 was 3.91%.

NeuPath Health's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. NeuPath Health's annualized ROC % for the quarter that ended in Jun. 2024 was 7.61%. NeuPath Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 30.48%.


NeuPath Health Operating Income Historical Data

The historical data trend for NeuPath Health's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuPath Health Operating Income Chart

NeuPath Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
-0.66 -0.82 -1.84 -1.26 0.44

NeuPath Health Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.01 0.02 0.24 0.74

NeuPath Health Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeuPath Health  (TSXV:NPTH) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

NeuPath Health's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=2.952 * ( 1 - 15.42% )/( (32.295 + 33.301)/ 2 )
=2.4968016/32.798
=7.61 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

NeuPath Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2.672/( ( (8.805 + max(-0.015999999999998, 0)) + (8.729 + max(-0.058999999999997, 0)) )/ 2 )
=2.672/( ( 8.805 + 8.729 )/ 2 )
=2.672/8.767
=30.48 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.576 + 0 + 0.547) - (8.139 + 0 + 0)
=-0.015999999999998

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.781 + 0 + 0.453) - (8.293 + 0 + 0)
=-0.058999999999997

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

NeuPath Health's Operating Margin % for the quarter that ended in Jun. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=0.738/18.88
=3.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


NeuPath Health Operating Income Related Terms

Thank you for viewing the detailed overview of NeuPath Health's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


NeuPath Health Business Description

Traded in Other Exchanges
N/A
Address
181 Bay Street, Suite 2100, Toronto, ON, CAN, M5J 2T3
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.
Executives
Daniel Chicoine Director
Joseph Andrew Walewicz Director
Daniel Marcel Legault Director
Grishanth Ram Ram Director
Grant Connelly Senior Officer
Stephen Lemieux Senior Officer

NeuPath Health Headlines

No Headlines